NT_1170x120_1-11-18

PDUFA

HDA, NACDS CEOs: Rx importation not worth risk

HDA, NACDS CEOs: Rx importation not worth risk

Efforts to promote the importation of prescription drugs — seen by some as one way to mitigate the escalating cost of medications — could compromise the safety of the U.S. pharmaceutical supply chain, according to HDA’s John Gray and NACDS’ Steve Anderson. In a blog post on Monday for the policy journal The Hill, Gray,